CATHERINE PAGE: Open Payments
NPI 1538699483 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,236 in 130 payments from 17 companies in 2025. Trend: 2023 $3,497 · 2024 $3,259 · 2025 $2,236
Food & beverage: $2,236
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $513 |
| Amgen Inc. | 36 | $410 |
| Novartis Pharmaceuticals Corporation | 19 | $329 |
| UCB, Inc. | 9 | $161 |
| Mallinckrodt Hospital Products Inc. | 5 | $141 |
| Radius Health, Inc. | 4 | $113 |
| GENZYME CORPORATION | 3 | $97 |
| Janssen Biotech, Inc. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
Products named: SKYRIZI, COSENTYX, RINVOQ, OTEZLA, Bimzelx, ACTHAR, EVENITY, KEVZARA.
Industry payments across MS — which companies pay providers there.
